Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Casi Phrmactcls Inc (CASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 225,142
  • Shares Outstanding, K 65,070
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,450 K
  • 36-Month Beta 1.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.36

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.32 +49.14%
on 11/10/17
4.42 -21.72%
on 12/04/17
+0.90 (+35.16%)
since 11/08/17
3-Month
0.99 +249.49%
on 09/13/17
4.84 -28.51%
on 10/11/17
+2.41 (+229.52%)
since 09/08/17
52-Week
0.91 +280.22%
on 06/20/17
4.84 -28.51%
on 10/11/17
+2.10 (+154.41%)
since 12/08/16

Most Recent Stories

More News
CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer SymposiumTM (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC)

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs announces a poster presentation on ENMD-2076...

CASI : 3.46 (+5.49%)
Global Biotechnology Market Showing Potential for Further Growth

According to a report by Global Market Insights, Inc., the Biotechnology Market size will exceed USD 775.2 billion with 9.9% CAGR from 2016 to 2024. Based on technology, the industry is segmented into...

ADMP : 4.60 (-1.08%)
COSM : 0.8000 (+14.29%)
INFI : 1.99 (+0.51%)
CASI : 3.46 (+5.49%)
PLX : 0.62 (-4.62%)
CASI Pharmaceuticals Reports Third Quarter 2017 Financial Results

CASI Pharmaceuticals, Inc. (the "Company") (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other...

CASI : 3.46 (+5.49%)
Cancer Immunotherapy Technology Projected to Create Further Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14 billion by 2022, growing at a CAGR of 14.5 percent from the time period of 2016...

CLDX : 3.03 (+3.41%)
ARQL : 1.51 (-0.66%)
RGBP : 0.0745 (-0.13%)
RGBPP : 0.0560 (unch)
ECYT : 4.94 (+3.35%)
CASI : 3.46 (+5.49%)
Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx - Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tandem Diabetes Care, Inc....

VHC : 3.80 (-5.00%)
TNDM : 2.40 (unch)
ROKA : 0.98 (-2.97%)
PZRX : 1.00 (+1.01%)
SAEX : 1.56 (-1.89%)
CASI : 3.46 (+5.49%)
CASI Pharmaceuticals, Capital Raise, Analysts Review, Product Development, and Guidance

NEW YORK, NY / ACCESSWIRE / October 31, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

CASI : 3.46 (+5.49%)
CASI Pharmaceuticals Announces $23.8 Million Registered Direct Offering Led By Existing Shareholders

CASI Pharmaceuticals, Inc. (the "Company") (Nasdaq: CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other...

CASI : 3.46 (+5.49%)
CASI Provides Pipeline Development Update

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs today provided an update to its pipeline.

CASI : 3.46 (+5.49%)
CASI Pharmaceuticals To Present At The Annual Rodman & Renshaw Global Investment Conference

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs announces it will present at the 19th Annual...

CASI : 3.46 (+5.49%)
CASI Pharmaceuticals Reports Second Quarter 2017 Financial Results

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, today reported financial results for the three...

CASI : 3.46 (+5.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic...

See More

Key Turning Points

2nd Resistance Point 3.72
1st Resistance Point 3.59
Last Price 3.46
1st Support Level 3.27
2nd Support Level 3.08

See More

52-Week High 4.84
Last Price 3.46
Fibonacci 61.8% 3.34
Fibonacci 50% 2.88
Fibonacci 38.2% 2.41
52-Week Low 0.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.